Related content

Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist

By Schroder A.K.   Schopper B.   Al-Hasani S.   Loning M.   Diedrich K.   Ludwig M.  

Fertility and Sterility, Vol. 79, Iss. 3, 2003-03 ,pp. : 648-650

Elsevier

Access to resources Recommend Favorite

A potential new use for gonadotropin-releasing hormone antagonists

By Aust T.R.   Sklavounos J.   Kingsland C.R.   Gazvani R.  

Fertility and Sterility, Vol. 80, Iss. 3, 2003-09 ,pp. : 641-642

Elsevier

Access to resources Recommend Favorite

Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles

By Ricciarelli E.   Sanchez M.   Martinez M.   Andres L.   Cuadros J.   Hernandez E.R.  

Fertility and Sterility, Vol. 79, Iss. 6, 2003-06 ,pp. : 1461-1463

Elsevier

Access to resources Recommend Favorite

Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up

By Kolibianakis E.   Bourgain C.   Albano C.   Osmanagaoglu K.   Smitz J.   Van Steirteghem A.   Devroey P.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1025-1029

Elsevier

Access to resources Recommend Favorite

Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist

By Williams S.C.   Gibbons W.E.   Muasher S.J.   Oehninger S.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1068-1072

Elsevier

Access to resources Recommend Favorite